Is a complete MNOV research report available?

No complete published report is available for MediciNova, Inc. (MNOV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MediciNova, Inc. (MNOV)

NASDAQ: MNOV · USD

$1.44

+0.03 (+2.1%)· Recorded snapshot

Market cap	70.9M
Revenue (ttm)	920.5K
Net income (ttm)	-10.8M
EPS (ttm)	-$0.22
Shares out	49.2M
Volume	23,865
Beta	0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 920.5K
Net income (ttm): -10.8M
EPS (ttm): -$0.22
Market cap: 70.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001226616
Company name	MediciNova, Inc.
Country	United States
Country code	US
CUSIP number	58468P206
Earnings date	2026-11-11
Earnings time	amc
Employees	6
Employees change	-7
Employees growth	-53.85%
Enterprise value	$45.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2000
Industry	Biotechnology
IPO date	2005-02-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US58468P2065
Last 10-K release date	2026-03-10
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$70.9M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$1.44
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MNOV
U.S. state	California
Website	https://medicinova.com

Metric

Value

Amount currency

USD

CIK code

0001226616

Company name

MediciNova, Inc.

Country

United States

Country code

CUSIP number

58468P206

Earnings date

2026-11-11

Earnings time

amc

Employees

Employees change

-7

Employees growth

-53.85%

Enterprise value

$45.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2000

Industry

Biotechnology

IPO date

2005-02-08

Is primary listing

Yes

Is SPAC

ISIN number

US58468P2065

Last 10-K release date

2026-03-10

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$70.9M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$1.44

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

MNOV

U.S. state

California

Website

https://medicinova.com

Metric	Value
Earnings yield	-15.19%
EV/Sales	47.91x
FCF / EV yield	-20.69%
FCF yield	-13.15%
Forward EV/Sales	529.26x
Forward P/S	832.86x
P/B ratio	1.86x
P/S ratio	75.4x
Price / tangible book value	3.03x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-15.19%

EV/Sales

47.91x

FCF / EV yield

-20.69%

FCF yield

-13.15%

Forward EV/Sales

529.26x

Forward P/S

832.86x

P/B ratio

1.86x

P/S ratio

75.4x

Price / tangible book value

3.03x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	37.75%
Operating margin	-1,287.41%
Pretax margin	-1,167.55%
Profit per employee	$-1.8M
Revenue per employee	$153,414
ROA	-16.41%
ROA (5Y)	-11.46%
ROCE	-31.62%
ROE	-25.56%
ROE (5Y)	-17.8%
ROIC	-17.52%
SBC / revenue	100.25%
Tax / revenue	0.65%

Metric

Value

Gross margin

37.75%

Operating margin

-1,287.41%

Pretax margin

-1,167.55%

Profit per employee

$-1.8M

Revenue per employee

$153,414

ROA

-16.41%

ROA (5Y)

-11.46%

ROCE

-31.62%

ROE

-25.56%

ROE (5Y)

-17.8%

ROIC

-17.52%

SBC / revenue

100.25%

Tax / revenue

0.65%

Metric	Value
EPS growth quarters	3
EPS growth years	0
Gross profit growth	1,803.8%
Gross profit growth (Q)	1,641.15%
Gross profit growth 5Y	-38.66%
Net income growth quarters	3
Net income growth years	0
Revenue growth	583.87%
Revenue growth (Q)	240.6%
Revenue growth (QoQ)	145.18%
Revenue growth 5Y	-25.46%
Revenue growth quarters	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

1,803.8%

Gross profit growth (Q)

1,641.15%

Gross profit growth 5Y

-38.66%

Net income growth quarters

Net income growth years

Revenue growth

583.87%

Revenue growth (Q)

240.6%

Revenue growth (QoQ)

145.18%

Revenue growth 5Y

-25.46%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-13,724
Depreciation and amortization	$19,138
EBIT	$-11.9M
EBITDA	$-11.8M
EPS	$-0.22
FCF per share	$-0.19
Financing cash flow	$244,018
Free cash flow	$-9.1M
Free cash flow minus SBC	$-10M
Gross profit	$347,443
Income taxes	$5,994
Investing cash flow	$-13,724
Net cash flow	$-8.8M
Net income	$-10.8M
Operating cash flow minus SBC	$-10M
Operating income	$-11.9M
Revenue	$920,481
Stock-based compensation	$922,783

Metric

Value

Capital expenditures

$-13,724

Depreciation and amortization

$19,138

EBIT

$-11.9M

EBITDA

$-11.8M

EPS

$-0.22

FCF per share

$-0.19

Financing cash flow

$244,018

Free cash flow

$-9.1M

Free cash flow minus SBC

$-10M

Gross profit

$347,443

Income taxes

$5,994

Investing cash flow

$-13,724

Net cash flow

$-8.8M

Net income

$-10.8M

Operating cash flow minus SBC

$-10M

Operating income

$-11.9M

Revenue

$920,481

Stock-based compensation

$922,783

Metric	Value
Altman Z-Score	-2.69
Book value per share	$0.76
Debt / equity	0
Goodwill	$9.6M
Long-term assets	$14.5M
Long-term liabilities	$201,792
Net cash (debt)	$25.3M
Net cash / market cap	36.45%
Net cash growth	-25.5%
Net debt / equity	-0.68
Piotroski F-Score	3
Property, plant and equipment	$111,803
Shareholders' equity	$37.3M
Tangible book value	$22.9M
Tangible book value per share	$0.46
Total assets	$40.4M
Total cash	$25.4M
Total debt	$117,038
Total liabilities	$3.2M
WACC	7.62%

Metric

Value

Altman Z-Score

-2.69

Book value per share

$0.76

Debt / equity

Goodwill

$9.6M

Long-term assets

$14.5M

Long-term liabilities

$201,792

Net cash (debt)

$25.3M

Net cash / market cap

36.45%

Net cash growth

-25.5%

Net debt / equity

-0.68

Piotroski F-Score

Property, plant and equipment

$111,803

Shareholders' equity

$37.3M

Tangible book value

$22.9M

Tangible book value per share

$0.46

Total assets

$40.4M

Total cash

$25.4M

Total debt

$117,038

Total liabilities

$3.2M

WACC

7.62%

Metric	Value
Asset turnover	0.02
Current assets	$25.9M
Current liabilities	$3M
Current ratio	8.75
Net working capital	$-2.3M
Quick ratio	8.58
Working capital	$23M
Working capital turnover	0.03

Metric

Value

Asset turnover

0.02

Current assets

$25.9M

Current liabilities

$3M

Current ratio

8.75

Net working capital

$-2.3M

Quick ratio

8.58

Working capital

$23M

Working capital turnover

0.03

Metric	Value
Buyback yield / dilution	-0.21%
Dividend yield	0%
Shareholder yield	-0.21%

Metric

Value

Buyback yield / dilution

-0.21%

Dividend yield

Shareholder yield

-0.21%

Metric	Value
10Y price change	-79.69%
10Y return CAGR	-14.74%
10Y total return	-79.69%
150-day SMA	$1.51
15Y price change	-40.74%
15Y return CAGR	-3.43%
15Y total return	-40.74%
1D price change	2.13%
1M price change	-44.19%
1M total return	-44.19%
1W price change	5.88%
1W total return	5.88%
1Y price change	19.5%
1Y return CAGR	19.52%
1Y total return	19.5%
20-day SMA	$1.50
200-day SMA	$1.51
3M price change	9.09%
3M total return	9.09%
3Y price change	-25%
3Y return CAGR	-9.14%
3Y total return	-25%
50-day SMA	$1.79
50-day SMA vs 200-day SMA	50over200
52-week high	$3.90
52-week high date	2026-09-17
52-week low	$1.17
52-week low date	2025-10-30
5Y price change	-58.5%
5Y return CAGR	-16.13%
5Y total return	-58.5%
6M price change	5.11%
6M total return	5.11%
All-time high	$16.12
All-time high date	2006-12-13
All-time low	$1.12
All-time low date	2024-08-12
Average true range (ATR)	$0.13
Average volume	97.6K
Beta (1Y)	0.53
Beta (2Y)	0.53
Beta (5Y)	0.61
Change from 52-week high	-63.08%
Change from 52-week low	23.29%
Change from all-time high	-91.07%
Change from all-time low	28.57%
Change from open	1.41%
Day's gap	0.71%
Dollar volume	$34,366
High price	$1.53
Low price	$1.40
Monthly RSI	46.91
Open price	$1.42
Position in 52-week range	30.77%
Premarket change	5.67%
Premarket close	$1.41
Premarket price	$1.49
Previous close	$1.41
Price vs 150-day SMA	-4.38%
Price vs 20-day SMA	-4.26%
Price vs 200-day SMA	-4.89%
Price vs 50-day SMA	-19.46%
Relative volume	0.24
RSI	39.61
Sharpe ratio	0.55
Sharpe ratio (3Y)	0.14
Sharpe ratio (5Y)	-0.04
Sortino ratio	1.17
Sortino ratio (3Y)	0.37
Sortino ratio (5Y)	0.03
Volume	23.9K
Weekly RSI	47.28
YTD price change	9.92%
YTD total return	9.92%

Metric

Value

10Y price change

-79.69%

10Y return CAGR

-14.74%

10Y total return

-79.69%

150-day SMA

$1.51

15Y price change

-40.74%

15Y return CAGR

-3.43%

15Y total return

-40.74%

1D price change

2.13%

1M price change

-44.19%

1M total return

-44.19%

1W price change

5.88%

1W total return

5.88%

1Y price change

19.5%

1Y return CAGR

19.52%

1Y total return

19.5%

20-day SMA

$1.50

200-day SMA

$1.51

3M price change

9.09%

3M total return

9.09%

3Y price change

-25%

3Y return CAGR

-9.14%

3Y total return

-25%

50-day SMA

$1.79

50-day SMA vs 200-day SMA

50over200

52-week high

$3.90

52-week high date

2026-09-17

52-week low

$1.17

52-week low date

2025-10-30

5Y price change

-58.5%

5Y return CAGR

-16.13%

5Y total return

-58.5%

6M price change

5.11%

6M total return

5.11%

All-time high

$16.12

All-time high date

2006-12-13

All-time low

$1.12

All-time low date

2024-08-12

Average true range (ATR)

$0.13

Average volume

97.6K

Beta (1Y)

0.53

Beta (2Y)

0.53

Beta (5Y)

0.61

Change from 52-week high

-63.08%

Change from 52-week low

23.29%

Change from all-time high

-91.07%

Change from all-time low

28.57%

Change from open

1.41%

Day's gap

0.71%

Dollar volume

$34,366

High price

$1.53

Low price

$1.40

Monthly RSI

46.91

Open price

$1.42

Position in 52-week range

30.77%

Premarket change

5.67%

Premarket close

$1.41

Premarket price

$1.49

Previous close

$1.41

Price vs 150-day SMA

-4.38%

Price vs 20-day SMA

-4.26%

Price vs 200-day SMA

-4.89%

Price vs 50-day SMA

-19.46%

Relative volume

0.24

RSI

39.61

Sharpe ratio

0.55

Sharpe ratio (3Y)

0.14

Sharpe ratio (5Y)

-0.04

Sortino ratio

1.17

Sortino ratio (3Y)

0.37

Sortino ratio (5Y)

0.03

Volume

23.9K

Weekly RSI

47.28

YTD price change

9.92%

YTD total return

9.92%

Metric	Value
Float	42.9M
Float percentage	87.25%
Shares change (QoQ)	0%
Shares change (YoY)	0.21%
Shares held by insiders	2.87%
Shares held by institutions	10.56%
Shares outstanding	49.2M
Short % of float	0.68%
Short % of shares	0.59%
Short ratio	0.4 days

Metric

Value

Float

42.9M

Float percentage

87.25%

Shares change (QoQ)

Shares change (YoY)

0.21%

Shares held by insiders

2.87%

Shares held by institutions

10.56%

Shares outstanding

49.2M

Short % of float

0.68%

Short % of shares

0.59%

Short ratio

0.4 days

MediciNova, Inc. (MNOV)

Price

Financial snapshot

Fair-value bridge

Latest news · MNOV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MNOV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MNOV

Frequently asked questions